FDA Registration, Listing & Facility Licensing — Common Pitfalls and Best Practices
Cut through recurring FDA registration, listing, and facility licensing errors — avoid misclassifications, missed updates, and common pitfalls under 21 CFR Part 807 and Part 820.
Instructor
Meredith Crabtree
GMP Quality Consultant & Validation Specialist
What You'll Learn
About the event
This course cuts through recurring FDA registration, listing, and facility licensing errors that delay approvals and trigger avoidable findings, translating regulatory requirements into clear, defensible actions.
Where organizations go wrong is assuming guidance equals execution. Misaligned product classifications, incomplete listings, missed updates, and unclear responsibilities surface during inspections, enforcement actions, and downstream submissions — often long after the error was made.
This webinar delivers practical clarity on how FDA expects registrations, listings, and licenses to be established and maintained, and helps teams avoid common traps under 21 CFR Part 807 and Part 820.
Code: FDB1413
Curriculum
Requirements
- QA, Regulatory Affairs, Manufacturing, and Operations professionals
- Applicable to supply chain, contract manufacturing oversight, and compliance teams
Meet Your Instructor
Meredith Crabtree
GMP Quality Consultant & Validation Specialist
Meredith Crabtree has over 30 years' experience in regulated industries, ranging from Blood, Plasma, Tissue, Laboratory, Pharma, Medical Device, Cosmetics, Supplements, and Animal Health. This includes manufacturing, packaging, labelling and distribution operations. Meredith is the owner of MLKC Consulting and specializes in product label reviews, 3rd party inspections, Consent Decree and Recall support. She also performs regulatory assessments and Quality trainings.
Event Details
Format
Recorded Webinar
Duration
1.5 hours
Certificate
Included
Access
Lifetime
Related Events
Digital Quality Metrics and AI/ML Analytics: Building a Continuous-Improvement Framework that Aligns with Regulatory Expectations
Learn how AI/ML and real-time digital quality metrics build a continuous-improvement framework aligned with FDA regulatory expectations, 21 CFR Part 11, and GAMP®5.
Carolyn Troiano
AI in GMP: What the FDA Is Already Expecting - Before You Ask
FDA already expects GMP compliance for AI systems. Learn how existing validation, data integrity, and oversight rules apply—before regulators come calling.
Dr. Ginette Collazo
HPLC Analytical Method Development and Validation
Master HPLC instrument and method validation to meet US EPA and FDA requirements for pharmaceutical analysis.
Dr. John C. Fetzer